Next Vial Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 5.7/10
Best for: compounded semaglutide at $249.97/month
Next Vial falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
An online marketplace that connects patients to licensed providers for compounded semaglutide and tirzepatide injections, microdose options included. It is LegitScript verified and names its dispensing pharmacy: Manifest Pharmacy in Greer, SC. There is no membership required, and one price covers the consultation, the medication and free shipping. It serves 49 states.
Is Next Vial legit?
Yes. Next Vial is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 5.7/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Next Vial promo or coupon code?
We know of no promo or coupon code for Next Vial. Its listed price is $249.97 a month. Coupon sites advertising "Next Vial discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Next Vial compares on our rankings of the best semaglutide providers.
Vetted alternatives to Next Vial
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Next Vial at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249.97/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 49 states
- FDA status
- No FDA warning letters found
How Next Vial scores
Six columns, each one computed from something Next Vial has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
2.8/10$249.97/month is 35% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
8.5/10Dispenses semaglutide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
9.8/10Serves 49 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Next Vial
Last checked August 2026- Checked the listed price across 1 dose or plan tier
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Next Vial
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Next Vial involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Next Vial shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Next Vial which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $249.97. That leaves out membership fees, first-month rates and insurance copays.
- Next Vial serves 49 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications Next Vial offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Starting monthly rate for GLP-1 program; tirzepatide rate not published.
Check the price yourself before you pay
Every figure here was read off Next Vial's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price includes the medication, clinician visits and shipping
- Serves 49 states
- We found no FDA warning letters issued to Next Vial
Against it
- Semaglutide costs $249.97 a month, 35% above the $185 median for compounded semaglutide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Next Vial charges
Next Vial lists $249.97/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
- Compounded semaglutide: $249.97/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Next Vial's $249.97 is a premium, and a premium has to buy something. Check what is bundled before you accept it.
Direct Meds dispenses semaglutide and tirzepatide from $249/month, which makes it the fair comparison to run before you commit here.
What Next Vial dispenses
Next Vial prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
Safety and disclosure
Next Vial tells you that it treats patients in all 50 states. We found no FDA warning letters issued to Next Vial. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Next Vial will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Next Vial bills your plan before you start.
It fits if
- you need access wherever you live
Our read
Next Vial costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why Next Vial scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
Next Vial falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay Next Vial
Starting at $249.97 a month. Check today's price, then start the intake.
Where Next Vial is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Next Vial head to head
The sellers closest to Next Vial on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Next Vial review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Next Vial's current pricing
Plans start at $249.97 a month. Whether you qualify is a clinician's decision, made after your intake.